Molecular engineering of CRISPR/Cas12a: from activity enhancement to exponential signal amplification
- 1Department of Chemistry, School of Science, Tianjin University, Tianjin 300072, P. R. China
- 2State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Centre for Analytical Sciences, College of Chemistry, Nankai University, Tianjin 300071, P. R. China
Abstract
CRISPR/Cas12a has emerged as a powerful tool for molecular diagnostics, yet its inherent linear signal output and limited amplification efficiency constrain its detection sensitivity. Conventional approaches that rely on coupling with pre-amplification techniques increase operational complexity and introduce potential uncertainties, thereby hindering clinical translation. This review highlights a paradigm shift: moving beyond the canonical "one-target-one-enzyme" model through molecular engineering to intrinsically enhance the catalytic activity of CRISPR/Cas12a and even achieve exponential signal amplification. We systematically summarize key strategies, including crRNA reprogramming, activator strand engineering, reporter probe design, and reaction environment optimization, that collectively enhance Cas12a's kinetics, specificity, and intrinsic signal output. These integrated engineering approaches enable ultrasensitive, pre-amplification-free detection of both nucleic acids and non-nucleic acid targets, paving the way for the next generation of robust and field-deployable point-of-care diagnostics.
Related
- Strategic enhancement of Cas9 nickase-driven gene amplification
- Isothermal Strand Displacement Amplification for Chemical Sensing: From Molecular Design to Integrated and Intelligent Platforms.
- An online, open-access, cost comparison tool for presumptive tuberculosis testing using low complexity, automated, nucleic acid amplification tests (LCaNAAT) versus near point-of-care (NPOCs) molecular tests
- Model-Guided Engineering of NS1-Truncated Influenza OP7 Particles with Enhanced Interferon-Mediated Antiviral Activity
- Loop engineering and activity improvement of TEV protease by a phagemid-based selection system
BibTeX
@article{li2026molecular,
title = {{Molecular engineering of CRISPR/Cas12a: from activity enhancement to exponential signal amplification}},
author = {Qing-Nan Li and Qi-Fan Yang and Wei-Liang Jin and Xiaozhe Pang and Wen-Bo Sun and Jia Xin Wang and Xin Yue Wang and An‐Na Tang and Deming Kong and Li-Na Zhu},
journal = {Chemical Science},
year = {2026},
month = jun,
doi = {10.1039/d6sc02276f},
url = {https://doi.org/10.1039/d6sc02276f},
note = {CC BY},
}
RIS
TY - JOUR
TI - Molecular engineering of CRISPR/Cas12a: from activity enhancement to exponential signal amplification
AU - Qing-Nan Li
AU - Qi-Fan Yang
AU - Wei-Liang Jin
AU - Xiaozhe Pang
AU - Wen-Bo Sun
AU - Jia Xin Wang
AU - Xin Yue Wang
AU - An‐Na Tang
AU - Deming Kong
AU - Li-Na Zhu
PY - 2026
DA - 2026/06/10
JO - Chemical Science
DO - 10.1039/d6sc02276f
UR - https://doi.org/10.1039/d6sc02276f
AB - CRISPR/Cas12a has emerged as a powerful tool for molecular diagnostics, yet its inherent linear signal output and limited amplification efficiency constrain its detection sensitivity. Conventional approaches that rely on coupling with pre-amplification techniques increase operational complexity and introduce potential uncertainties, thereby hindering clinical translation. This review highlights a paradigm shift: moving beyond the canonical "one-target-one-enzyme" model through molecular engineering to intrinsically enhance the catalytic activity of CRISPR/Cas12a and even achieve exponential signal amplification. We systematically summarize key strategies, including crRNA reprogramming, activator strand engineering, reporter probe design, and reaction environment optimization, that collectively enhance Cas12a's kinetics, specificity, and intrinsic signal output. These integrated engineering approaches enable ultrasensitive, pre-amplification-free detection of both nucleic acids and non-nucleic acid targets, paving the way for the next generation of robust and field-deployable point-of-care diagnostics.
SN - 2041-6520
SN - 2041-6539
ER -